Myeloproliferative neoplasm classification: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 3: | Line 3: | ||
{{CMG}}{{AE}} {{MJK}} | {{CMG}}{{AE}} {{MJK}} | ||
==Overview== | ==Overview== | ||
Myeloproliferative | Myeloproliferative neoplasm may be classified according to the World Health Organization into eight subtypes: [[chronic myelogenous leukemia]], [[chronic neutrophilic leukemia]], [[polycythemia vera]], [[primary myelofibrosis]], [[essential thrombocythemia]], [[chronic eosinophilic leukemia]], [[mastocytosis]], and myeloproliferative neoplasms, unclassifiable.<ref name="pmid19357394">{{cite journal| author=Vardiman JW, Thiele J, Arber DA, Brunning RD, Borowitz MJ, Porwit A et al.| title=The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. | journal=Blood | year= 2009 | volume= 114 | issue= 5 | pages= 937-51 | pmid=19357394 | doi=10.1182/blood-2009-03-209262 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19357394 }} </ref> | ||
==Classification== | ==Classification== | ||
Myeloproliferative | Myeloproliferative neoplasm may be classified according to the World Health Organization into eight subtypes:<ref name="pmid19357394">{{cite journal| author=Vardiman JW, Thiele J, Arber DA, Brunning RD, Borowitz MJ, Porwit A et al.| title=The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. | journal=Blood | year= 2009 | volume= 114 | issue= 5 | pages= 937-51 | pmid=19357394 | doi=10.1182/blood-2009-03-209262 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19357394 }} </ref><ref name="pmid11377686">{{cite journal| author=Valent P, Horny HP, Escribano L, Longley BJ, Li CY, Schwartz LB et al.| title=Diagnostic criteria and classification of mastocytosis: a consensus proposal. | journal=Leuk Res | year= 2001 | volume= 25 | issue= 7 | pages= 603-25 | pmid=11377686 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11377686 }} </ref> | ||
* [[Chronic myelogenous leukemia]], ''[[BCR]]-[[ABL1]]''–positive | * [[Chronic myelogenous leukemia]], ''[[BCR]]-[[ABL1]]''–positive | ||
* [[Chronic neutrophilic leukemia]] | * [[Chronic neutrophilic leukemia]] | ||
Revision as of 13:54, 22 October 2015
|
Myeloproliferative Neoplasm Microchapters |
|
Differentiating myeloproliferative neoplasm from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Myeloproliferative neoplasm classification On the Web |
|
American Roentgen Ray Society Images of Myeloproliferative neoplasm classification |
|
Directions to Hospitals Treating Myeloproliferative neoplasm |
|
Risk calculators and risk factors for Myeloproliferative neoplasm classification |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2]
Overview
Myeloproliferative neoplasm may be classified according to the World Health Organization into eight subtypes: chronic myelogenous leukemia, chronic neutrophilic leukemia, polycythemia vera, primary myelofibrosis, essential thrombocythemia, chronic eosinophilic leukemia, mastocytosis, and myeloproliferative neoplasms, unclassifiable.[1]
Classification
Myeloproliferative neoplasm may be classified according to the World Health Organization into eight subtypes:[1][2]
- Chronic myelogenous leukemia, BCR-ABL1–positive
- Chronic neutrophilic leukemia
- Polycythemia vera
- Primary myelofibrosis
- Essential thrombocythemia
- Chronic eosinophilic leukemia, not otherwise specified
- Mastocytosis
- Myeloproliferative neoplasms, unclassifiable
References
- ↑ 1.0 1.1 Vardiman JW, Thiele J, Arber DA, Brunning RD, Borowitz MJ, Porwit A; et al. (2009). "The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes". Blood. 114 (5): 937–51. doi:10.1182/blood-2009-03-209262. PMID 19357394.
- ↑ Valent P, Horny HP, Escribano L, Longley BJ, Li CY, Schwartz LB; et al. (2001). "Diagnostic criteria and classification of mastocytosis: a consensus proposal". Leuk Res. 25 (7): 603–25. PMID 11377686.